Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro

Chronic treatment with the mTOR inhibitor, everolimus, fails long-term in preventing tumor growth and dissemination in cancer patients. Thus, patients experiencing treatment resistance seek complementary measures, hoping to improve therapeutic efficacy. This study investigated metastatic characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Justin, Saira, Rutz, Jochen, Maxeiner, Sebastian, Chun, Felix K.-H., Juengel, Eva, Blaheta, Roman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432076/
https://www.ncbi.nlm.nih.gov/pubmed/32759798
http://dx.doi.org/10.3390/ijms21155582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432076/
https://www.ncbi.nlm.nih.gov/pubmed/32759798
http://dx.doi.org/10.3390/ijms21155582

Ejemplares similares